about
Pyk2 activates the NLRP3 inflammasome by directly phosphorylating ASC and contributes to inflammasome-dependent peritonitisRapid identification of M. abscessus and M. massiliense by MALDI-TOF mass spectrometry with a comparison to sequencing methods and antimicrobial susceptibility patterns.Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes.Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology.Cul4A is an oncogene in malignant pleural mesothelioma.Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.Histological differentiation of primary oral squamous cell carcinomas in an area of betel quid chewing prevalence.Development of a multiplexed assay for oral cancer candidate biomarkers using peptide immunoaffinity enrichment and targeted mass spectrometry.Proteomic profiling of the cancer cell secretome: informing clinical research.Quantitative analysis of wild-type and V600E mutant BRAF proteins in colorectal carcinoma using immunoenrichment and targeted mass spectrometry.Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study.Proteomics analysis of EV71-infected cells reveals the involvement of host protein NEDD4L in EV71 replication.Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma.Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis.Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.Cysteine protease cathepsin B mediates radiation-induced bystander effects.Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling.Curcumin prevents methylglyoxal-induced oxidative stress and apoptosis in mouse embryonic stem cells and blastocysts.Oxidation of protein-bound methionine in Photofrin-photodynamic therapy-treated human tumor cells explored by methionine-containing peptide enrichment and quantitative proteomics approach.Binding of the extreme carboxyl-terminus of PAK-interacting exchange factor β (βPIX) to myosin 18A (MYO18A) is required for epithelial cell migration.Analysis of the efficacy of Taiwanese freeze-dried neurotoxic antivenom against Naja kaouthia, Naja siamensis and Ophiophagus hannah through proteomics and animal model approaches.MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2.Development of a Multiplexed Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry (LC-MRM/MS) Method for Evaluation of Salivary Proteins as Oral Cancer Biomarkers.Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma.Variability Assessment of 90 Salivary Proteins in Intraday and Interday Samples from Healthy Donors by Multiple Reaction Monitoring-Mass Spectrometry.Integrated omics profiling identifies hypoxia-regulated genes in HCT116 colon cancer cells.Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.Targeting HSP60 by subcutaneous injections of jetPEI/HSP60-shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth.Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery.Proteomic characterization of six Taiwanese snake venoms: Identification of species-specific proteins and development of a SISCAPA-MRM assay for cobra venom factorsHuman ATP-binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY-1215) in cancer cell linesSystematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimensBretschneider solution-induced alterations in the urine metabolome in cardiac surgery patientsDevelopment of sandwich ELISA and lateral flow strip assays for diagnosing clinically significant snakebite in TaiwanMacrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis
P50
Q28822592-E088C178-E099-45CB-B27C-6C0D6C26B1FDQ31143061-3A3BD029-C058-4CC0-AE93-6376B8A93B71Q33220040-a87cbc9e-4c3e-6d31-3e12-7ad335d4fd72Q33315273-18f90302-499f-e1bf-d6d1-46405e9298ceQ33861095-949243FE-A114-4FCA-8BD7-E96D90190B3FQ33888970-80EC5A57-9C7F-455A-B99B-D357C89D17DEQ34000411-f6aff5dc-445c-47b9-a6c1-f7a99f07bedeQ35971585-1eafd3e0-4acc-fbef-770a-d85af8006198Q36386895-1e4e8459-48e2-d5be-b8ea-8df10a45c923Q37346934-12ECECDD-4E4A-4448-B869-140B1E425B4CQ37637295-40167aac-4ddd-29ec-7b53-3bbeae273902Q38640227-BF18E3BE-7243-43CA-85DB-C519F8E10539Q38659528-A187C600-3143-4B95-8DF9-12C402ADE6A5Q38753503-F62C774B-08DE-4FFF-8F08-D558AF1F9AA8Q38825662-1A64E0BD-4E78-4641-8C72-B4324465015CQ38898147-7ADE7CEE-56B1-457E-99FA-830443267487Q39089823-F57E359F-84B8-447E-92EC-DB64299872AAQ39516021-d4cbe15a-4f2e-ed23-37d1-827bb8834ba3Q39675956-678946fa-4d3e-9bb5-e4ea-b1f4d046a0f3Q40063761-8322C456-DBAC-4F25-A199-234558362496Q40127864-1CC54B2D-A909-497E-BCC2-E8FA1F038B3EQ40192981-24920f97-4779-3b0b-2ce5-5ee8b3e8d8d6Q40424017-85342d6b-4696-f3ed-11f0-673fd9eddac4Q42268148-ACBE4CE8-D427-42BA-8523-D34FADAA5C48Q45421490-3B785A68-D4DA-41B9-9EFA-B1CE410DF567Q46240361-4221BB75-4165-4AAD-B7DC-7487DDCFE610Q47133718-8A06A3EA-B15E-4719-B210-34EA63EF5EC2Q48196134-D2D0F181-5887-4B5F-9724-B40C17B7B93AQ48831873-F7E041E7-97DD-4EB8-96C7-EC448FEE39E6Q49923464-C83273A8-6259-4828-859C-A2BA79630B75Q51148422-233F29A0-BD10-4B50-9D9D-68928D474ACAQ51743373-02E02219-3CBB-4C13-B55F-3006FCE365C0Q52577689-57F60B41-4CDD-4427-8C84-3AED27000707Q52649606-56D3EF51-6D03-45AD-96CF-CB85C388B7BFQ57156906-52B00B18-4A11-4D5A-B5AE-A70C060EBE90Q57162579-4755227F-81BD-4756-B9AF-4877D3C954F2Q57175284-0C2A8238-8711-4038-9697-72760A80F006Q60045712-A4911AE7-0E47-4413-B2CF-64E465A1DD84Q60309409-59DC26C1-3B56-442A-BE47-B6D4BA15346AQ61796006-CBC9C60E-E7CB-48DD-B32C-D4775E6F7578
P50
description
Taiwanese molecular biologist
@en
wetenschapper
@nl
name
Yu Jau-song
@en
Yu Jau-song
@nl
余兆松
@zh
type
label
Yu Jau-song
@en
Yu Jau-song
@nl
余兆松
@zh
altLabel
Jau-Song Yu
@en
prefLabel
Yu Jau-song
@en
Yu Jau-song
@nl
余兆松
@zh
P4012
P2038
Jau-Song_Yu
P31
P4012
P496
0000-0002-4295-983X
P6023
2136509243_Jau-Song_Yu